Carl Zeiss Meditec (OTCMKTS:CZMWY) Shares Down 7% – Here’s Why

by · The Cerbat Gem

Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) shares traded down 7% on Thursday . The company traded as low as $45.96 and last traded at $47.10. 3,519 shares changed hands during trading, a decline of 8% from the average session volume of 3,816 shares. The stock had previously closed at $50.67.

Analyst Upgrades and Downgrades

Separately, Barclays assumed coverage on Carl Zeiss Meditec in a research note on Tuesday, September 9th. They issued an “overweight” rating on the stock. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold”.

Read Our Latest Stock Report on CZMWY

Carl Zeiss Meditec Stock Performance

The firm has a 50-day moving average of $51.16 and a 200-day moving average of $55.41.

Carl Zeiss Meditec Company Profile

(Get Free Report)

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Featured Stories